Table 2.
Operative data
| Procedure | Number | Percent |
|---|---|---|
| Isolated SAVR |
128 |
68.1% |
| SAVR + other |
60 |
31.9% |
| AscAo |
21 |
11.2% |
| MVR |
16 |
8.5% |
| CABG |
13 |
6.9% |
| CABG + other |
5 |
2.6% |
| Myectomie |
3 |
1.6% |
| Closure of VSD |
1 |
0.5% |
| Passive Cardiomyoplasty* |
1 |
0.5% |
| Surgical approach |
|
|
| Median sternotomy |
182 |
96.8% |
| Upper ministernotomy |
6 |
3.2% |
| Implanted valves |
|
|
| Edwards Prima-Plus® |
120 |
63.8% |
| SJM Toronto-SPV® |
50 |
26.6% |
| Medtronik FreeStyle® |
10 |
5.3% |
| Vascutec Elan® |
7 |
3.7% |
| Shelhigh-stentless® |
1 |
0.5% |
| Implanted valve sizes |
|
|
| 23 mm |
3 |
1.6% |
| 25 mm |
35 |
18.6% |
| 27 mm |
79 |
42.0% |
| 29 mm | 71 | 37.8% |
AscAo = Replacement of ascending aorta; VSD = ventrical septal defect; CABG = coronary artery bypass grafting; MVR = mitral valve repair/ replacement; * = ACORN® Cardiac Support Device.